An 18-year-old female patient presented to the emergency department with non-specific neurological and gastrointestinal symptoms and was found to be pancytopenic. Her vitamin B 12 level was low with a normal mean corpuscular volume and her full blood count 2 months previously had been within normal range. She reported heavy use of nitrous oxide over the previous 2 weeks and other investigations revealed no cause for her pancytopenia. Her pancytopenia resolved with discontinuation of nitrous oxide and vitamin B 12 treatment. Heavy use of nitrous oxide should be considered as a cause of pancytopenia.
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An 18-year-old female patient presented to the emergency department following a collapse at home. She reported feeling dizzy on walking to her bed and then collapsed and was found unconscious on the floor by her partner who reported that she was unresponsive for 1 minute. On further questioning the patient reported a 1-week history of dizziness, nausea and vomiting, and a 1 day history of urinary frequency, dark urine and intermittent lower abdominal pain. She had no past medical history other than a previous appendicectomy and was not on any regular medications. On examination she was haemodynamically stable and afebrile. She had multiple oral ulcers and some tenderness on palpation of the left flank but otherwise examination was unremarkable.
Initial investigations revealed a pancytopenia with a haemoglobin of 101 g/L, mean corpuscular volume (MCV) 86.7 fL, white cell count 2.0 x 10 9 /L (neutrophils 0.7 x 10 9 /L) and platelets 83 x 10 9 /L. The blood film was reported as: 'Occasional small platelet clumps although platelet count does appear to be genuinely low. Moderate neutropenia, the neutrophils seen appear well granulated and mature'. Other routine blood investigations were normal other than a slightly raised C-reactive protein of 10.3 mg/L, and chest radiography was unremarkable. Urinalysis was positive for nitrites with traces of leucocytes, blood and protein, β-human chorionic gonadotrophin was negative. She ABSTRACT was diagnosed with pyelonephritis and treated with gentamicin and co-amoxiclav. Her haematological parameters continued to deteriorate (see Table 1 ) so she was reverse barrier nursed and her antibiotics changed to piperacillin/tazobactam, but she remained clinically well and afebrile. Urine cultures were negative. Further investigations included a negative viral screen (HIV, hepatitis B and C, Epstein-Barr virus and cytomegalovirus), negative autoimmune screen and unremarkable abdominal ultrasound. Her haematinics showed a ferritin of 185 μg/L (10-120 μg/L), serum iron 10 mmol/L (9-30 mmol/L), transferrin 2.3 g/L (1.7-3.4 g/L), transferrin saturation 17% (16-55%), folate 17.1 μg/L (>2.7 μg/L) and vitamin B 12 <125 ng/L (160-800 ng/L). A full blood count 2 months prior to admission was normal (Table 1 ) .
On further questioning the patient admitted to having inhaled approximately 350 canisters of nitrous oxide (N 2 O) over the preceding fortnight and prior to this inhaling approximately two canisters weekly for 4 months. On discussion with a haematologist, vitamin B 12 replacement was commenced in the form of intramuscular hydroxocobalamin 1 mg daily on day six of admission. By day nine her haematological parameters had recovered sufficiently for her to be discharged and her treatment was continued in primary care. A full blood count 6 weeks after her admission was within normal limits (Table 1 ) .
Discussion
N 2 O is a colourless, sweet-tasting gas that was discovered by Joseph Priestley in 1772, and its medical use was popularised by Sir Humphrey Davy who reported its pain relieving and euphoric effects in 1784. It is used as an anaesthetic for dental operations, during labour and for acute pain. However its euphoric and relaxing effects and hallucinogenic properties have led to its use as a recreational drug known as 'hippy crack' or 'laughing gas'. In 2014 the Global Drug Survey reported that 38.6% of UK respondents reported ever using N 2 O and 20.4% of respondents reported N 2 O use in the last year. 1 
Lesson of the month

5-methyl-tetrahydrofolate to tetrahydrofolate (THF)
. THF is the precursor of thymidine monophosphate required for the synthesis of deoxyribonucleic acid and reduced THF accounts for its effects on haematopoiesis. In addition accumulation of methylmalonic acid leads to demyelination of neurons resulting in neurological damage. Most cases of N 2 O toxicity reported in the literature present with neurological symptoms caused by myeloneuropathy and subacute combined degeneration of the cord. 5 In some cases haematological abnormalities were also documented 6 although in others they were not present. 7 We could only find one report in which N 2 O was linked to bone marrow failure without neurological symptoms, although the patient presented with altered mental status. 8 
